Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis) [Clinical Sciences]
Conclusions—Symptomatic ISR occurred in at least 1 of 7 patients in SAMMPRIS by 3 years of follow-up and was likely responsible for the majority of nonprocedural cerebral infarctions.Clinical Trial Registration—URL: https://clinicaltrials.gov. Unique identifier: NCT00576693.
Source: Stroke - Category: Neurology Authors: Colin P. Derdeyn, David Fiorella, Michael J. Lynn, Tanya N. Turan, George A. Cotsonis, Bethany F. Lane, Jean Montgomery, L. Scott Janis, Marc I. Chimowitz Tags: Cerebrovascular Disease/Stroke, Ischemic Stroke, Restenosis, Stenosis Original Contributions Source Type: research